Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$893K Sell
25,259
-144
-0.6% -$4.47K 0.01% 662
2025
Q4
$706K Sell
25,403
-1,543
-6% -$46.2K 0.01% 771
2025
Q3
$808K Buy
26,946
+2,632
+11% +$74.2K 0.01% 694
2025
Q2
$696K Buy
24,314
+3,502
+17% +$104K 0.01% 735
2025
Q1
$687K Sell
20,812
-2,910
-12% -$94.9K 0.01% 690
2024
Q4
$683K Buy
23,722
+3,737
+19% +$107K 0.01% 736
2024
Q3
$576K Buy
19,985
+1,914
+11% +$51K 0.01% 833
2024
Q2
$441K Buy
+18,071
New +$443K 0.01% 871
2018
Q3
Sell
-10,086
Closed -$415K 221
2018
Q2
$415K Sell
10,086
-122
-1% -$5.56K 0.06% 143
2018
Q1
$592K Buy
10,208
+19
+0.2% +$1.11K 0.07% 137
2017
Q4
$558K Hold
10,189
0.07% 143
2017
Q3
$518K Buy
10,189
+29
+0.3% +$1.55K 0.07% 147
2017
Q2
$589K Buy
10,160
+69
+0.7% +$4.01K 0.08% 129
2017
Q1
$590K Sell
10,091
-5
-0% -$284 0.09% 122
2016
Q4
$561K Buy
+10,096
New +$540K 0.09% 121

Other funds holding ALKS

Choreo LLC's ALKS Position: Q1 2026 in Review

Choreo LLC reduced its Alkermes (ALKS) stake by 0.57% in Q1 2026, selling an estimated $4.47K and leaving 25,259 shares worth $893K. The position accounts for 0.01% of the portfolio, ranked #662.

Choreo LLC first reported a position in ALKS in Q4 2016 and has held it in 15 quarters since. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Choreo LLC held 25,259 shares of Alkermes worth $893K as of Q1 2026.
  • Choreo LLC sold 144 Alkermes shares in Q1 2026, an estimated $4.47K.
  • Alkermes made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #662 holding.
  • Choreo LLC first reported a position in Alkermes in Q4 2016 and has held it in 15 quarters since.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.